GLUE
Common StockMonte Rosa Therapeutics, Inc.
Reported Shares
3.2M
Position Mix
No options reported
Reported Value
$37.9M
Portfolio Weight
34.85%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$108.9M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
GLUE
Common StockMonte Rosa Therapeutics, Inc.
Reported Shares
3.2M
Position Mix
No options reported
Reported Value
$37.9M
Portfolio Weight
34.85%
IPSC
Common StockCentury Therapeutics, Inc.
Reported Shares
12.2M
Position Mix
No options reported
Reported Value
$20.8M
Portfolio Weight
19.11%
CTNM
Common StockContineum Therapeutics, Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$17.3M
Portfolio Weight
15.93%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
991.8K
Position Mix
No options reported
Reported Value
$13.9M
Portfolio Weight
12.80%
LENZ
Common StockLENZ Therapeutics, Inc.
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$10.2M
Portfolio Weight
9.37%
CRSP
Common StockCRISPR Therapeutics AG
Reported Shares
148.8K
Position Mix
No options reported
Reported Value
$8.2M
Portfolio Weight
7.56%
SKYE
Common StockSkye Bioscience, Inc.
Reported Shares
251K
Position Mix
No options reported
Reported Value
$404.0K
Portfolio Weight
0.37%